Monte Rosa Therapeutics, Inc. (GLUE) reported Q2 Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. MRNA
2. KEYS
3. KLAR
4. PANW
5. MRK
6. HD
7. SPY
8. DVLT
9. NBIS
10. PGR

Go back to Monte Rosa Therapeutics, Inc. (GLUE) reported Q2 Revenue
(NASDAQ: GLUE) Delayed: 15.77 +0.74 (4.92%)
Previous Close $15.03    52 Week High $ 
Open $15.58    52 Week Low $ 
Day High $16.21    P/E N/A 
Day Low $15.35    EPS $ 
Volume 1,070,234